Sarikaya Ilker A, Gorgun Baris, Erdal Ozan A
aOrtopediatri Clinic bDepartment of Orthopaedics and Traumatology, Ortopediatri Clinic, Sisli, Istanbul, Turkey.
J Pediatr Orthop B. 2017 Nov;26(6):546-551. doi: 10.1097/BPB.0000000000000338.
Atelosteogenesis type III is a rare autosomal dominant skeletal dysplasia caused by mutations in the synthesis of the protein filamin B (FLNB). The mutation in the gene coding for FLNB causes the osteochondrodysplastic features of this disorder. Clinically, osteochondrodysplasia causes unbalanced skeletal maturation and absent or mostly hypoplastic bones, such as the pelvis, vertebrae, ribs, or long bones. In the literature, an orthopedic management for this disorder has not been well described. We report the case and orthopedic management of a 6-year-old female patient with atelosteogenesis type III after 3 years of follow-up.
III型atelosteogenesis是一种罕见的常染色体显性遗传性骨骼发育不良,由细丝蛋白B(FLNB)合成中的突变引起。编码FLNB的基因突变导致了该疾病的骨软骨发育不良特征。临床上,骨软骨发育不良会导致骨骼成熟不平衡以及骨骼缺失或大部分发育不全,如骨盆、椎骨、肋骨或长骨。在文献中,尚未对该疾病的骨科治疗方法进行充分描述。我们报告了一名6岁III型atelosteogenesis女性患者,经过3年随访后的病例及骨科治疗情况。